
large patient populations.7,30,31 The role of TF-CAS or transcervical carotid artery revascularization (TCAR) is even less
clear because no completed studies have compared
these treatments for patients with asymptomatic carotid
stenosis against best medical therapy.
Several upcoming, multicenter randomized trials have
been designed to answer the role of modern pharmacologic therapy in the management of asymptomatic
carotid stenosis. These trials include